Basit öğe kaydını göster

dc.contributor.authorFuruichi, T.
dc.contributor.authorKayserili, H.
dc.contributor.authorHiraoka, S.
dc.contributor.authorNishimura, G.
dc.contributor.authorOhashi, H.
dc.contributor.authorAlanay, Y.
dc.contributor.authorLerena, J. C.
dc.contributor.authorAslanger, A. D.
dc.contributor.authorKoseki, H.
dc.contributor.authorCohn, D. H.
dc.contributor.authorSuperti-Furga, A.
dc.contributor.authorUnger, S.
dc.contributor.authorIkegawa, S.
dc.date.accessioned2019-12-10T10:38:52Z
dc.date.available2019-12-10T10:38:52Z
dc.date.issued2009
dc.identifier.issn0022-2593
dc.identifier.urihttps://doi.org/10.1136/jmg.2008.065201
dc.identifier.urihttp://hdl.handle.net/11655/14084
dc.description.abstractBackground: Schneckenbecken dysplasia (SBD) is an autosomal recessive lethal skeletal dysplasia that is classified into the severe spondylodysplastic dysplasias (SSDD) group in the international nosology for skeletal dysplasias. The radiological hallmark of SBD is the snail-like configuration of the hypoplastic iliac bone. SLC35D1 (solute carrier-35D1) is a nucleotide-sugar transporter involved in proteoglycan synthesis. Recently, based on human and mouse genetic studies, we showed that loss-of-function mutations of the SLC35D1 gene (SLC35D1) cause SBD. Object: To explore further the range of SLC35D1 mutations in SBD and elucidate whether SLC35D1 mutations cause other skeletal dysplasias that belong to the SSDD group. Methods and results: We searched for SLC35D1 mutations in five families with SBD and 15 patients with other SSDD group diseases, including achodrogenesis type 1A, spondylometaphyseal dysplasia Sedaghatian type and fibrochondrogenesis. We identified four novel mutations, c.319C>T (p.R107X), IVS4+3A>G, a 4959-bp deletion causing the removal of exon 7 (p.R178fsX15), and c.193A>C (p.T65P), in three SBD families. Exon trapping assay showed IVS4+3A>G caused skipping of exon 4 and a frameshift (p.L109fsX18). Yeast complementation assay showed the T65P mutant protein lost the transporter activity of nucleotide sugars. Therefore, all these mutations result in loss of function. No SLC35D1 mutations were identified in all patients with other SSDD group diseases. Conclusion: Our findings suggest that SLC35D1 loss-of-function mutations result consistently in SBD and are exclusive to SBD.
dc.language.isoen
dc.publisherBmj Publishing Group
dc.relation.isversionof10.1136/jmg.2008.065201
dc.rightsinfo:eu-repo/semantics/openAccess
dc.subjectGenetics & Heredity
dc.titleIdentification Of Loss-Of-Function Mutations Of Slc35D1 In Patients With Schneckenbecken Dysplasia, But Not With Other Severe Spondylodysplastic Dysplasias Group Diseases
dc.typeinfo:eu-repo/semantics/article
dc.typeinfo:eu-repo/semantics/publishedVersion
dc.relation.journalJournal Of Medical Genetics
dc.contributor.departmentÇocuk Sağlığı ve Hastalıkları
dc.identifier.volume46
dc.identifier.issue8
dc.identifier.startpage562
dc.identifier.endpage568
dc.description.indexWoS


Bu öğenin dosyaları:

Bu öğe aşağıdaki koleksiyon(lar)da görünmektedir.

Basit öğe kaydını göster